A random effects variance shift model for detecting and accommodating outliers in meta-analysis

BMC Med Res Methodol. 2011 Feb 16:11:19. doi: 10.1186/1471-2288-11-19.

Abstract

Background: Meta-analysis typically involves combining the estimates from independent studies in order to estimate a parameter of interest across a population of studies. However, outliers often occur even under the random effects model. The presence of such outliers could substantially alter the conclusions in a meta-analysis. This paper proposes a methodology for identifying and, if desired, downweighting studies that do not appear representative of the population they are thought to represent under the random effects model.

Methods: An outlier is taken as an observation (study result) with an inflated random effect variance. We used the likelihood ratio test statistic as an objective measure for determining whether observations have inflated variance and are therefore considered outliers. A parametric bootstrap procedure was used to obtain the sampling distribution of the likelihood ratio test statistics and to account for multiple testing. Our methods were applied to three illustrative and contrasting meta-analytic data sets.

Results: For the three meta-analytic data sets our methods gave robust inferences when the identified outliers were downweighted.

Conclusions: The proposed methodology provides a means to identify and, if desired, downweight outliers in meta-analysis. It does not eliminate them from the analysis however and we consider the proposed approach preferable to simply removing any or all apparently outlying results. We do not however propose that our methods in any way replace or diminish the standard random effects methodology that has proved so useful, rather they are helpful when used in conjunction with the random effects model.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Algorithms
  • Analysis of Variance*
  • Brain Diseases / drug therapy
  • Brain Diseases / psychology
  • Cytidine Diphosphate Choline / therapeutic use
  • Data Interpretation, Statistical*
  • Dental Caries / prevention & control
  • Fluorides
  • Humans
  • Likelihood Functions
  • Magnesium / therapeutic use
  • Meta-Analysis as Topic*
  • Myocardial Infarction / drug therapy
  • Nootropic Agents / therapeutic use
  • Research Design
  • Toothpastes
  • Treatment Outcome

Substances

  • Nootropic Agents
  • Toothpastes
  • Cytidine Diphosphate Choline
  • Magnesium
  • Fluorides